Discovery of a Highly Potent, Orally Active Mitosis/Angiogenesis Inhibitor R1530 for the Treatment of Solid Tumors-Reference-Cited by-同舟云学术

Discovery of a Highly Potent, Orally Active Mitosis/Angiogenesis Inhibitor R1530 for the Treatment of Solid Tumors

Published:2013-01-22 Issue:2 Volume:4 Page:259-263
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Liu Jin-Jun¹,Higgins Brian¹,Ju Grace¹,Kolinsky Kenneth¹,Luk Kin-Chun¹,Packman Kathryn¹,Pizzolato Giacomo¹,Ren Yi¹,Thakkar Kshitij¹,Tovar Christian¹,Zhang Zhuming¹,Wovkulich Peter M.¹

Affiliation:

1. Discovery Chemistry, ‡Discovery Oncology, and §Chemical Synthesis, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml300351e

Reference26 articles.

1. Folkman, J.Cancer Medicine;Williams and Wilkins:Baltimore, MD, 1997; pp181–204.

2. Anti-Angiogenesis

3. Angiogenesis: an organizing principle for drug discovery?

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15

2. Alternative Reactions to Friedel-crafts Acylation on Highly Activated Substrates;Current Organic Chemistry;2024-07

3. Therapeutic potential of targeting polo-like kinase 4;European Journal of Medicinal Chemistry;2024-02

4. High-yielding regioselective synthesis of p-quinone fused 5-substituted-1,4-benzodiazepine scaffolds via Pictet–Spengler type cycloannulation;New Journal of Chemistry;2024

5. Direct Access to Quinone-Fused 5-Substituted-1,4-Benzodiazepine Scaffolds from Azidoquinones with/without [1,2]-Azide-Nitrogen Migration: Mechanistic Insights;The Journal of Organic Chemistry;2023-11-15